Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy

Comparative and Functional Genomics

Volumn 5, Issue 6-7, 2004, Pages 459-470

  Strøm, Claes C ^a   Kruhøffer, Mogens ^b   Knudsen, Steen ^c   Stensgaard Hansen, Frank ^a   Jonassen, Thomas E N ^a   Ørntoft, Torben F ^b   Haunsø, Stig ^a   Sheikh, Søren P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Cardiac hypertrophy; DNA microarrays; Gene expression; Remodelling

Indexed keywords

GENOMIC DNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA DISEASE; ARTERIOVENOUS SHUNT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DNA MICROARRAY; DRUG INDUCED DISEASE; GENE EXPRESSION; GENE IDENTIFICATION; GENE PROBE; GENE TECHNOLOGY; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; MOLECULAR GENETICS; NEWBORN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

EID: 13444274361     PISSN: 15316912     EISSN: None     Source Type: Journal    
DOI: 10.1002/cfg.428     Document Type: Article

References (23)

1. Agabiti-Rosei E, Muiesan ML. 1997. Prognostic significance of left ventricular hypertrophy regression. Adv Exp Med Biol 432 199-205.
2. Anversa P, Levicky V, Beghi C, McDonald SL, Kikkawa Y. 1983. Morphometry of exercise-induced right ventricular hypertrophy in the rat. Circ Res 52: 57-64.
3. Aronow BJ, Toyokawa T, Canning A, et al. 2001. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genom 6: 19-28.
4. Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC. 2002. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160: 2035-2043.
5. Bateman A, Bennett HJP. 1998. Granulins: the structure and function of a emerginc family of growth factores. J Endocrinol 158: 145-151.
6. Busk PK, Bartkova J, Strom CC, et al. 2002. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 56: 64-75.
7. Chien KR, Knowlton KU, Zhu H, Chien S. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5 3037-3046.
8. Friddle CJ, Koga T, Rubin EM, Bristow J. 2000. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 97: 6745-6750.
9. Golub TR, Slonim DK, Tamayo P, et al. 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
10. Hwang DM, Dempsey AA, Lee CY, Liew CC. 2000. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 66: 1-14.
11. Hwang JJ, Allen PD, Tseng GC, et al. 2002. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genom 10: 31-44.
12. La M, D'Amico M, Bandiera S, et al. 2001. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J 15: 2247-2256.
13. Li C, Hung Wong W. 2001a. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2.
14. Li C, Wong WH. 2001b. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36.
15. Liau LM, Lallone RL, Seitz RS, et al. 2000. Identification of a human glioma-associated growth factor gene, granulin, using differential immunoadsorption. Cancer Res 60: 1353-1360.
16. Roberts CJ, Nelson B, Marton MJ, et al. 2000. Signalling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287: 873-880.
17. Schoenfeld JR, Vasser M, Jhurani P, et al. 1998. Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy. J Mol Cell Cardiol 30: 2269-2280.
18. Sehl PD, Tai JT, Hillan KJ, et al. 2000. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101: 1990-1999.
19. Stanton LW, Garrard LJ, Damm D, et al. 2000. Altered patterns of gene expression in response to myocardial infarction. Circ Res 86: 939-945.
20. 2+ influx regulates growth plate chondrocyte maturation and apoptosis. J Biol Chem 278: 3762-3769.
21. Weinberg EO, Mirotsou M, Gannon J, et al. 2003. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genom 12: 113-127.
22. Wollert KC, Taga T, Saito M, et al. 1996. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271 9535-9545.
23. Yang J, Moravec CS, Sussman MA, et al. 2000. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102: 3046-3052.